Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05120544 · ClinicalTrials.gov registry record · NA
Expanding Technology-Enabled Nurse Delivered Chronic Disease Care
A NA study of Hypertension and Diabetes Mellitus, Type 2, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 220
- Enrollment target
- 1
- Study location
NCT05120544: Completed NA study of Hypertension and Diabetes Mellitus, Type 2, sponsored by Duke University.
NCT05120544 is a NA study of Hypertension and Diabetes Mellitus, Type 2 that has completed, run by Duke University. The registered enrollment target is 220 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05120544, a NA study of Hypertension and Diabetes Mellitus, Type 2, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 220 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate whether the self-management of diabetes and hypertension can be improved with the use of mobile monitoring devices and nursing support.
Primary Outcome
Change in blood sugar (glucose) attached to hemoglobin. Validated point-of-care or lab-based test.
Conditions Studied
Interventions
- BEHAVIORAL EXTEND Plus
- BEHAVIORAL EXTEND
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2022-04-21 |
| Est. Completion | 2025-08-13 |
| Phase | NA |
What the finished NCT05120544 record still lists
NCT05120544 is an interventional study that assigns participants to a tested intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which EXTEND Plus is the first listed.
NCT05120544 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05120544 about?
NCT05120544 is a clinical study titled "Expanding Technology-Enabled Nurse Delivered Chronic Disease Care". The purpose of this study is to investigate whether the self-management of diabetes and hypertension can be improved with the use of mobile monitoring devices and nursing support.
What is the current status of trial NCT05120544?
This trial is currently completed. It is a NA study. The enrollment target is 220 participants. The study started on 2022-04-21. Estimated completion is 2025-08-13.
What conditions does trial NCT05120544 study?
This clinical trial studies the following conditions: Hypertension, Diabetes Mellitus, Type 2.
What interventions are being tested in trial NCT05120544?
The interventions under investigation include: EXTEND Plus (BEHAVIORAL), EXTEND (BEHAVIORAL).
Who is sponsoring clinical trial NCT05120544?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05120544 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05120544's enrollment target sits among peer trials
220 206th of 470 higher than 262 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00920972 · 220 participants · Phase 1
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- NCT01851642 · 220 participants
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- NCT02582021 · 220 participants
WISE CVD - Continuation (WISE HFpEF)
- NCT04067830 · 220 participants · Phase 2
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI